Literature DB >> 7091722

Isoniazid-induced enflurane defluorination in humans.

R I Mazze, R E Woodruff, M E Heerdt.   

Abstract

Serum inorganic fluoride (F-) levels were measured in 20 surgical patients treated with 300 mg isoniazid per day for periods of up to one year, prior to anesthesia with enflurane. Thirty-six control patients anesthetized with enflurane, but taking no drugs, also were studied. Regression lines for peak serum fluoride were plotted against enflurane exposure in MAC-hours. Nine isoniazid-treated patients had fluoride levels significantly (P less than 0.001) higher (y = 22.2x + 12.0) than either the 11 other isoniazid-treated patients (y = 5.0x + 8.2) or the 36 control patients (y = 5.4x + 6.3). Peak serum fluoride values in three patients exceeded 100 microM but in no patient did values exceed 10 microM by 48 h after anesthesia. It was concluded that isoniazid treatment resulted in enzyme induction in the nine patients with high peak fluoride levels. This pattern, i.e., induction occurring in approximately one-half the patients, probably is related to the genetically determined bimodal distribution of rapid and slow acetylation of isoniazid.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7091722     DOI: 10.1097/00000542-198207000-00002

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  11 in total

Review 1.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  In vitro effects of fluoride and bromide on pseudocholinesterase and acetylcholinesterase activities.

Authors:  J R Kambam; W C Parris; R J Naukam; J J Franks; B V Sastry
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

Review 3.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

4.  Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes.

Authors:  H Yin; M W Anders; K R Korzekwa; L Higgins; K E Thummel; E D Kharasch; J P Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Effect of cimetidine on biotransformation of enflurane in man.

Authors:  M P Yeager; D W Coombs; C P Dodge; L L Maloney
Journal:  Can Anaesth Soc J       Date:  1986-07

6.  Fluorinated anaesthetic nephrotoxicity: an update.

Authors:  R I Mazze
Journal:  Can Anaesth Soc J       Date:  1984-05

Review 7.  Pharmacokinetic drug interactions in anaesthetic practice.

Authors:  M Wood
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 8.  Clinically significant drug interactions with antituberculosis agents.

Authors:  J M Grange; P A Winstanley; P D Davies
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

Review 9.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

Review 10.  Adverse effects of general anaesthetics.

Authors:  M C Berthoud; C S Reilly
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.